Daejeon, South Korea

Choonho Ryu

This inventor holds 1 USPTO granted patent. Top assignee: Sk Holdings Co., Ltd.. Active years: 2011.


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Choonho Ryu in Pharmaceutical Chemistry

Introduction

Choonho Ryu is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on addressing central nervous system disorders, showcasing his commitment to advancing healthcare solutions.

Latest Patents

Choonho Ryu holds a patent for "Phenyl piperazine compounds, pharmaceutical composition comprising the same, and use thereof." This invention relates to a novel piperazine derivative or pharmaceutically acceptable salt thereof. The patent outlines a process for preparing the compound and describes a pharmaceutical composition for treating central nervous system diseases. It emphasizes the effective use of the piperazine compound in treating disorders such as psychosis in mammals.

Career Highlights

Choonho Ryu is associated with Sk Holdings Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has garnered attention for its potential impact on treating complex neurological conditions. With a focus on research and development, he plays a crucial role in advancing therapeutic options for patients.

Collaborations

Choonho Ryu collaborates with talented individuals in his field, including coworkers Yunhee Kim and Seonmin Dong. Their combined expertise contributes to the success of their projects and enhances the research environment at Sk Holdings Co., Ltd.

Conclusion

Choonho Ryu's innovative work in pharmaceutical chemistry exemplifies the importance of research in developing effective treatments for central nervous system disorders. His contributions, particularly through his patent, highlight the potential for new therapeutic approaches in medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…